Calidi Biotherapeutics, Inc. (CLDWW)
Calidi Biotherapeutics, Inc. (CLDWW)
| Balance Sheets | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash | 6,631 | 10,375 | 5,279 | |
| Prepaid expenses and other current assets | 722 | 653 | 770 | |
| Total current assets | 7,353 | 11,028 | 6,049 | |
| Machinery and equipment, net | 758 | 849 | 929 | |
| Operating lease right-of-use assets, net | 1,342 | 2,012 | 2,333 | |
| Other noncurrent assets | 138 | 140 | 40 | |
| Total assets | 9,591 | 14,029 | 9,351 | |
| Accounts payable-Nonrelated Party | 849 | 1,143 | 1,215 | |
| Accounts payable-Related Party | 51 | 5 | 12 | |
| Accrued expenses and other current liabilities-Nonrelated Party | 1,313 | 1,396 | 1,493 | |
| Noncontrolling interest | NaN | 280 | 312 | |
| Accrued expenses and other current liabilities-Related Party | 119 | 778 | 441 | |
| Total equity | NaN | 7,198 | 2,076 | |
| Related party bridge loan payable, including accrued interest-Related Party | NaN | NaN | 0 | |
| Term notes payable, net of discount, including accrued interest-Related Party | NaN | 405 | 775 | |
| Related party other current liability-Related Party | NaN | NaN | 0 | |
| Finance lease liability, current | 154 | 112 | 113 | |
| Related party term notes payable, net of discount, including accrued interest-Nonrelated Party | NaN | NaN | 0 | |
| Operating lease right-of-use liability, current | 1,350 | 1,354 | 1,304 | |
| Total current liabilities | 3,836 | 5,193 | 5,353 | |
| Operating lease right-of-use liability, noncurrent | 6 | 640 | 993 | |
| Finance lease liability, noncurrent | 147 | 197 | 226 | |
| Promissory note | 600 | 600 | 600 | |
| Warrant liability | 62 | 186 | 96 | |
| Related party warrant liability | 5 | 15 | 7 | |
| Total liabilities | 4,656 | 6,831 | 7,275 | |
| Common stock, 0.0001 par value, 330,000 shares authorized 11,787 and 7,217 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 1 | 1 | NaN | |
| Additional paid-in capital | 150,685 | 144,495 | 134,193 | |
| Accumulated other comprehensive loss, net of tax | -22 | -13 | -13 | |
| Accumulated deficit | -145,729 | -137,565 | -132,416 | |
| Total equity | 4,935 | 6,918 | 1,764 | |
| Total liabilities and total equity | 9,591 | 14,029 | 9,351 | |